These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 35145164)
1. Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer. Kang E; Jung SC; Nam SK; Park Y; Seo SH; Park KU; Oh HK; Kim DW; Kang SB; Lee HS Sci Rep; 2022 Feb; 12(1):2295. PubMed ID: 35145164 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571 [TBL] [Abstract][Full Text] [Related]
3. Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer. Toiyama Y; Hur K; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A Ann Surg; 2014 Apr; 259(4):735-43. PubMed ID: 23982750 [TBL] [Abstract][Full Text] [Related]
4. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance. Sahami-Fard MH; Kheirandish S; Sheikhha MH Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340 [TBL] [Abstract][Full Text] [Related]
6. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations. Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896 [TBL] [Abstract][Full Text] [Related]
7. Low expression levels of microRNA-124-5p correlated with poor prognosis in colorectal cancer via targeting of SMC4. Jinushi T; Shibayama Y; Kinoshita I; Oizumi S; Jinushi M; Aota T; Takahashi T; Horita S; Dosaka-Akita H; Iseki K Cancer Med; 2014 Dec; 3(6):1544-52. PubMed ID: 25081869 [TBL] [Abstract][Full Text] [Related]
8. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
9. A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery. Shadbad MA; Asadzadeh Z; Derakhshani A; Hosseinkhani N; Mokhtarzadeh A; Baghbanzadeh A; Hajiasgharzadeh K; Brunetti O; Argentiero A; Racanelli V; Silvestris N; Baradaran B Biomed Pharmacother; 2021 Nov; 143():112213. PubMed ID: 34560556 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic potential of miR-200 family members in gingival crevicular fluid for chronic periodontitis: correlation with clinical parameters and therapeutic implications. Yu SL BMC Oral Health; 2023 Jul; 23(1):532. PubMed ID: 37525201 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of Serum miR-133b and miR-206 Associate with Clinical Outcomes of Progression as Monitoring Biomarkers for Metastasis Colorectal Cancer Patients. Wanram S; Klaewkla N; Pinyosri P Microrna; 2024; 13(1):56-62. PubMed ID: 38231064 [TBL] [Abstract][Full Text] [Related]
12. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients. Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464 [TBL] [Abstract][Full Text] [Related]
13. The distinct role of strand-specific miR-514b-3p and miR-514b-5p in colorectal cancer metastasis. Ren LL; Yan TT; Shen CQ; Tang JY; Kong X; Wang YC; Chen J; Liu Q; He J; Zhong M; Chen HY; Hong J; Fang JY Cell Death Dis; 2018 Jun; 9(6):687. PubMed ID: 29880874 [TBL] [Abstract][Full Text] [Related]
14. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer. Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530 [TBL] [Abstract][Full Text] [Related]
15. MiR-9-5p suppresses cell metastasis and epithelial-mesenchymal transition through targeting FOXP2 and predicts prognosis of colorectal carcinoma. Wang WX; Yu HL; Liu X Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6467-6477. PubMed ID: 31378886 [TBL] [Abstract][Full Text] [Related]
16. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients. Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644 [TBL] [Abstract][Full Text] [Related]
17. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Pichler M; Ress AL; Winter E; Stiegelbauer V; Karbiener M; Schwarzenbacher D; Scheideler M; Ivan C; Jahn SW; Kiesslich T; Gerger A; Bauernhofer T; Calin GA; Hoefler G Br J Cancer; 2014 Mar; 110(6):1614-21. PubMed ID: 24504363 [TBL] [Abstract][Full Text] [Related]
18. Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer. Sun Y; Yang B; Lin M; Yu H; Chen H; Zhang Z Cancer Biomark; 2019; 24(3):299-305. PubMed ID: 30829615 [TBL] [Abstract][Full Text] [Related]